Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines

Hepatobiliary and Pancreatic Diseases International

Volumn 10, Issue 1, 2011, Pages 95-100

  Cai, Hui Hua ^a,b   Sun, Yue Ming ^a   Miao, Yi ^a   Gao, Wen Tao ^a   Peng, Quan ^a   Yao, Jie ^a   Zhao, Han Lin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CpG island; Methylation; Pancreatic cancer; TNFRSF10C

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; GENOMIC DNA; RNA; TRICHOSTATIN A; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN CFPAC 1; CELL STRAIN PANC 1; CELL STRAIN PC 3; CELL STRAIN SW1990; COMBINED BISULFITE RESTRICTION ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FLOW CYTOMETRY; GENE MUTATION; GENE SEQUENCE; GENOME ANALYSIS; GENOMICS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NICK END LABELING; PANCREAS CANCER; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION MAPPING;

EID: 79952060606     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(11)60014-3     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002;2:420-430. (Pubitemid 37328939)
3. Van Geelen CM, de Vries EG, de Jong S. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist Updat 2004;7:345-358. (Pubitemid 40341956)
4. Tessema M, Yu YY, Stidley CA, Machida EO, Schuebel KE, Baylin SB, et al. Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers. Carcinogenesis 2009;30:1132-1138.
5. Chaib H, MacDonald JW, Vessella RL, Washburn JG, Quinn JE, Odman A, et al. Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors. Genes Chromosomes Cancer 2003;37:306-313. (Pubitemid 36667569)
6. Cheng Y, Kim JW, Liu W, Dunn TA, Luo J, Loza MJ, et al. Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer. Prostate 2009;69:327-335.
7. Wu Y, Alvarez M, Slamon DJ, Koeffler P, Vadgama JV. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. BMC Cancer 2010;10:32.
8. Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, et al. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer 2004;109:786-792. (Pubitemid 38405630)
9. Adams J, Williams SV, Aveyard JS, Knowles MA. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss. Cancer Res 2005;65:66-75. (Pubitemid 40070796)
10. van Noesel MM, van Bezouw S, Salomons GS, Voute PA, Pieters R, Baylin SB, et al. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. Cancer Res 2002;62:2157-2161. (Pubitemid 34408465)
11. Michalowski MB, de Fraipont F, Michelland S, Entz-Werle N, Grill J, Pasquier B, et al. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 2006;166:74-81.
12. Hornstein M, Hoffmann MJ, Alexa A, Yamanaka M, Müller M, Jung V, et al. Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer. Cancer Genomics Proteomics 2008;5:123-136. (Pubitemid 351642612)
13. Kim TY, Zhong S, Fields CR, Kim JH, Robertson KD. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res 2006;66:7490-7501. (Pubitemid 44289203)
14. Warnecke PM, Stirzaker C, Song J, Grunau C, Melki JR, Clark SJ. Identification and resolution of artifacts in bisulfite sequencing. Methods 2002;27:101-107. (Pubitemid 34757119)
15. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-2534. (Pubitemid 27303718)
16. Meng CF, Zhu XJ, Peng G, Dai DQ. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. Oncol Rep 2009;22:1221-1227.
17. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002;31:141-149.
18. Lai JC, Wu JY, Cheng YW, Yeh KT, Wu TC, Chen CY, et al. O6-Methylguanine-DNA methyltransferase hypermethylation modulated by 17beta-estradiol in lung cancer cells. Anticancer Res 2009;29:2535-2540.
19. Mahalingam D, Szegezdi E, Keane M, Jong S, Samali A. TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev 2009;35:280-288.
20. Tarragona J, Llecha N, Santacana M, Lopez S, Gatius S, Llobet D, et al. DcR1 expression in endometrial carcinomas. Virchows Arch 2010;456:39-44.
21. Klugman SD, Gross SJ, Liang J, Livne K, Gross B, Khabele D, et al. Expression of Keratin 8 and TNF-Related Apoptosis-I Inducing Ligand (TRAIL) in Down Syndrome Placentas. Placenta 2008;29:382-384.